Hadassah

Pollin Center Forges Ahead with Gender-Based Research and Advocacy

Thursday, Jan 22 2015

The Linda Joy Pollin Cardiovascular Wellness (LJPCW) Center for Women at the Hadassah Medical Organization is actively engaged in basic science and clinical research concerning gender health issues, as well as advocacy for gender health equity in research and treatment.

Basic Science Research.
The LJPCW Center has partnered with Dr. Rivka Pollak of the Endocrinology Department at Hadassah to investigate the female heart’s response to menopause. The study is identifying the differences in heart anatomy and function in mice once the ovaries are removed.

Clinical Research.
Two clinical cardiovascular studies are awaiting approvals and should begin shortly. One deals with the differences in the way men and women perceive chest pain as it relates to the signs and symptoms of a heart attack. The other will look at differences in the effects of anticoagulant drugs on women and men.

“We need consciousness raising regarding gender issues in medical research in Israel,” comments Dr. Donna Zfat-Zwas, Director of the LJPCW Center. “We have to put this issue on the radar screen of our medical and scientific colleagues.”

Dr. Zfat-Zwas notes that last October, the Pollin Center submitted a Policy Recommendation to Israel’s Knesset, advocating for gender equity in health care and research and greater awareness about gender issues. Dr. Zfat-Zwas and her colleagues at the Pollin Center are working with the Knesset Committee on the Advancement of Women and Gender Equity to educate medical professionals, legislators, and the general public as to the differential health needs of women throughout their lifecycle.

As the policy recommendation explains: “While in fields other than health, gender equality implies gender justice, this is not the case in health, as biological differences between the sexes give rise to differential health needs.” The recommendation continues by explaining that “gender equity refers to the different needs, preferences and interests of women and men” and advocates for policies and programs that aim to achieve gender equity in health through appropriate design and funding.”

The policy recommendation calls for initiatives in 4 areas: government policy, health services, research, and education. It also brings out that there are significant gaps in the knowledge and practice of physicians regarding gender health issues--particularly in cardiovascular health--and that gender medicine and women’s health are not routinely taught in medical school or during residencies. While professional organization guidelines address the issue, there are discrepancies between these guidelines and common medical practices.

The recommendation urges the Ministry of Health to make gender equity in health a national priority, whereby more sensitive indicators will be used to collect data that reflect the health differences between women and men. This data collection would then lead to a plan of action, as well as ongoing monitoring of progress achieved.

The recommendation also calls specifically for a mandate regarding gender equity in medical research, where researchers will be trained in gender issues. In addition, peer review for funding would take into consideration whether gender sensitivity is part of the study design—

whether the design considers, for example, gender differences in the effectiveness of a medication or treatment, as well as its potential toxicity in men and women.

All education in medical and paramedical fields, the policy proposes, should include gender training and a comprehensive gender medicine curriculum, which encompasses both basic sciences, such as genetics and anatomy, along with clinical medical specialties.

The goal is to provide quality health care to women throughout their lifecycle by remaining sensitive to the biological differences between men and women that lead to different health needs and outcomes.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More